Advertisement Cegedim introduces new solution REMS - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Cegedim introduces new solution REMS

Cegedim Relationship Management, a provider of Customer Relationship Management (CRM) services for the life sciences industry, has introduced compliance solution for Risk Evaluation and Mitigation Strategies (REMS), the Food and Drug Administration (FDA) required risk management program.

Cegedim Relationship Management’s REMS compliance solution includes compliance consulting, customer outreach, data analytics and a campaign management platform.

According to the company, REMS are risk management plans that can be required by the FDA to manage serious risks associated with a drug and the program is used to address the unique risk-benefit profile of a drug or its class.

Cegedim Relationship Management Global Compliance Solutions vice president Bill Buzzeo said the REMS solution spans the entire program lifecycle, including risk identification, implementation and communication throughout the distribution chain.

"By offering a fully integrated solution, we are providing a revolutionary system to easily monitor program activity and identify communication gaps that can be addressed in real-time," Buzzeo added.